Cha Hyun Ji, Han Chang-Hyun, Jeon Ju Hyun, Jeong Jeong Kyo, Jung In Chul, Yang Changsop, Kang Byoung-Kab, Kim Min Ji, Choi Young Eun, Kim Young Il
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Korean Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
J Pain Res. 2024 Jun 24;17:2203-2221. doi: 10.2147/JPR.S457425. eCollection 2024.
Pharmacopuncture therapy has been used in the conservative treatment of rotator cuff disease adjuvant to acupuncture treatment. Despite the increasing utilization of pharmacopuncture therapy, there is still a lack of high-quality research to support its effectiveness. This pilot study aimed to assess the feasibility of pharmacopuncture therapy adjuvant to acupuncture treatment for rotator cuff disease.
This was a parallel-grouped, pragmatic randomized controlled, pilot study. Forty patients were randomly allocated to either the experimental or the control group. All patients received acupuncture treatment for four weeks, and pharmacopuncture was additionally administered to the experimental group. After eight treatments were delivered over four weeks, follow-up assessments were performed. The primary outcome was the mean change in the visual analog scale (VAS) score for shoulder pain from baseline to visit 8. Secondary outcomes included shoulder pain and disability index (SPADI) at visits 4, 8, and 9, shoulder range of motion (ROM) at visits 4, 8, and 9, EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) at visits 8 and 9, patient global impression of change (PGIC) at visits 8 and 9, and mean rescue medication consumption at visits 8 and 9.
Both groups showed that each treatment effectively improved rotator cuff disease in most assessments. Particularly, the group that received acupuncture plus pharmacopuncture required fewer rescue medications than the group that received acupuncture alone. However, there was little statistically significant difference between the two groups. There were no serious adverse events experienced by patients in this study.
Although there was little statistical difference between the two groups, the combination of acupuncture and pharmacopuncture for rotator cuff disease was associated with a reduction in the rescue medicine dosage compared with acupuncture alone. Also, it confirmed the safety of pharmacopuncture therapy. This pilot study would help design future research on the effectiveness of pharmacopuncture in rotator cuff disease.
药物针灸疗法已被用于肩袖疾病的保守治疗,作为针灸治疗的辅助手段。尽管药物针灸疗法的应用越来越广泛,但仍缺乏高质量的研究来支持其有效性。本试点研究旨在评估药物针灸疗法辅助针灸治疗肩袖疾病的可行性。
这是一项平行分组、实用随机对照的试点研究。40名患者被随机分配到实验组或对照组。所有患者均接受为期四周的针灸治疗,实验组额外接受药物针灸治疗。在四周内进行八次治疗后,进行随访评估。主要结局是从基线到第8次就诊时肩部疼痛视觉模拟量表(VAS)评分的平均变化。次要结局包括第4、8和9次就诊时的肩部疼痛和功能障碍指数(SPADI)、第4、8和9次就诊时的肩部活动范围(ROM)、第8和9次就诊时的欧洲五维健康量表(EQ-5D-5L)、第8和9次就诊时的患者总体变化印象(PGIC),以及第8和9次就诊时的平均急救药物消耗量。
两组在大多数评估中均显示每种治疗方法都有效改善了肩袖疾病。特别是,接受针灸加药物针灸的组比仅接受针灸的组需要更少的急救药物。然而,两组之间在统计学上几乎没有显著差异。本研究中的患者未发生严重不良事件。
尽管两组之间在统计学上差异不大,但与单独使用针灸相比,针灸和药物针灸联合治疗肩袖疾病与急救药物剂量的减少有关。此外,它证实了药物针灸疗法的安全性。这项试点研究将有助于设计未来关于药物针灸治疗肩袖疾病有效性的研究。